Increased CSF PCSK9 is also correlated with specific AD biomarkers including amyloid β (Aβ42), phospho Tau (P-tau), and total Tau (T-tau) (Zimetti et al., 2017; Picard et al., 2019). The gene discussed is MAPT; the disease is Alzheimer disease.